You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Prevalence of possible drug-drug interactions between ritonavir and other antiretroviral drugs in a private health care sector in South Africa
- In: SIG: Pharmacoepidemiology/Pharmacoeconomics - Posters
- At: Basel (Switzerland) (2008)
- Type: Poster
- Poster code: PP-P-003
- By: TRUTER, Ilse (Drug Utilization Research Unit, Nelson Mandela Metropolitan University, Port Elizabeth, South Africa)
- Co-author(s): Katende-Kyenda, Norah (Department of Pharmacology, Walter Sisulu University, Mthatha, South Africa)
Lubbe, Martie (Pharmacy Practice, North-West University, Potchefstroom, South Africa)
Serfontein, Jan (Pharmacy Practice, North-West University, Potchefstroom, South Africa) - Abstract:
Background: The introduction of human immunodeficiency virus (HIV) protease inhibitors (PIs) has led to a dramatic decline in the morbidity and mortality associated with HIV infection, though concomitant use of PIs and other antiretrovirals (ARVs) can be complicated by drug-drug interactions (DDIs), adversely affecting levels of PIs.
..
Primary aim: The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026